MiR-30c regulates cisplatin-induced apoptosis of renal tubular epithelial cells by targeting Bnip3L and Hspa5
Open Access
- 10 August 2017
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 8 (8) , e2987
Abstract
As a common anticancer drug, cisplatin has been widely used for treating tumors in the clinic. However, its side effects, especially its nephrotoxicity, noticeably restrict the application of cisplatin. Therefore, it is imperative to investigate the mechanism of renal injury and explore the corresponding remedies. In this study, we showed the phenotypes of the renal tubules and epithelial cell death as well as elevated cleaved-caspase3- and TUNEL-positive cells in rats intraperitoneally injected with cisplatin. Similar cisplatin-induced cell apoptosis was found in HK-2 and NRK-52E cells exposed to cisplatin as well. In both models of cisplatin-induced apoptosis in vivo and in vitro, quantitative PCR data displayed reductions in miR-30a-e expression levels, indicating that miR-30 might be involved in regulating cisplatin-induced cell apoptosis. This was further confirmed when the effects of cisplatin-induced cell apoptosis were found to be closely correlated with alterations in miR-30c expression, which were manipulated by transfection of either the miR-30c mimic or miR-30c inhibitor in HK-2 and NRK-52E cells. Using bioinformatics tools, including TargetScan and a gene expression database (Gene Expression Omnibus), Adrb1, Bnip3L, Hspa5 and MAP3K12 were predicted to be putative target genes of miR-30c in cisplatin-induced apoptosis. Subsequently, Bnip3L and Hspa5 were confirmed to be the target genes after determining the expression of these putative genes following manipulation of miR-30c expression levels in HK-2 cells. Taken together, our current experiments reveal that miR-30c is certainly involved in regulating the renal tubular cell apoptosis induced by cisplatin, which might supply a new strategy to minimize cisplatin-induced nephrotoxicity.Keywords
This publication has 44 references indexed in Scilit:
- Urinary chemokine (C-C motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicityBiochemical Pharmacology, 2013
- Long-Term Outcome of Patients Followed by Nephrologists after an Acute Tubular Necrosis EpisodeInternational Journal of Nephrology, 2012
- High-throughput assessment of microRNA activity and function using microRNA sensor and decoy librariesNature Methods, 2012
- MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTLCarcinogenesis, 2012
- Dexamethasone Ameliorates Renal Ischemia-Reperfusion InjuryJournal of the American Society of Nephrology, 2009
- Autophagy is associated with apoptosis in cisplatin injury to renal tubular epithelial cellsAmerican Journal of Physiology-Renal Physiology, 2008
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003
- Immunohistochemical Study of Rat Renal Interstitial Fibrosis Induced by Repeated Injection of Cisplatin, with Special Reference to the Kinetics of Macrophages and MyofibroblastsToxicologic Pathology, 1996
- Critical subcellular targets of cisplatin and related platinum analogs in rat renal proximal tubule cellsKidney International, 1995
- Adverse effects of anti-tumor drug, cisplatin, on rat kidney mitochondria: Disturbances in glutathione peroxidase activityBiochemical and Biophysical Research Communications, 1989